Mass Cytometry

Mass Cytometry Platform

The International Microbiome Centre (IMC) Mass Cytometry Platform, in partnership with the Nicole Perkins Microbial Communities Lab, is a core facility specializing in high parameter single cell analysis using the CyTOF Helios technology.


Our vision is to use mass cytometry to harness the power of the microbiome for better living.


Our mission is to employ mass cytometry in microbiome research to gain a detailed understanding of host microbial interactions in health and disease. In alignment with the overall IMC mission, the Mass Cytometry Platform also offers the latest cutting-edge technologies for advancement of microbiome  research to a broad audience of researchers (internal and external), industry, and government including animal health, agriculture, energy and the environment. We promote standardization of mass cytometry protocols and are developing a global network for development of collaborations and partnerships to further enable translation of microbiome research.

Key Areas of Research

Microbiome & Chronic disease

Inflammatory bowel disease

Type 1 Diabetes

Cancer and cancer immuno-therapies

Early life immune education


Sepsis and intensive care medicine

Cystic fibrosis


Antibody panel design (human and mouse)

Antibody labelling for mass cytometry

Acquisition of samples

Data analysis support by IMC bioinformatics platform


Dr. Markus Geuking

Dr. Markus Geuking, PhD, Faculty Lead, Mass Cytometry Platform, International Microbiome Centre

Markus Geuking, PhD, is an Associate Professor in the Snyder Institute for Chronic Diseases and the Department of Microbiology, Immunology & Infectious Diseases at the University of Calgary. He obtained his PhD at the Swiss Federal Institute for Technology in the lab of Nobel Prize Laureate Prof. Rolf Zinkernagel in Zurich, Switzerland. Subsequently, he performed research at McMaster University in Hamilton as a postdoctoral fellow and at the University of Bern (Switzerland) as a research associate
before being recruited to the University of Calgary in 2016. He is a mucosal immunologist and his research team studies how the large number of beneficial bacteria within our intestines, that collectively form the intestinal microbiome, interact and shape our immune system in health and disease.


Shaunna Huston, ACCN RN, BSc, PhD Immunology

Director, Programs and Business, International Microbiome Centre
Phone: 403-220-6074